简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-06-18 14:00 Carestream Secures Crucial Business Partner Agreement in Peru
2024-06-18 09:45 Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome
2024-06-17 11:35 Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
2024-06-17 10:09 Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)
2024-06-14 16:29 Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024
2024-06-13 11:26 RegenLab France Receives Prestigious EU-EIB Innovation Champion Award
2024-06-13 11:17 GSK Enters Into a Multi-Year Data Licence Agreement With Ochre Bio to Further Investigate the Drivers of Liver Disease
2024-06-11 13:22 Hematology/Oncology: AOP Health’s Expanding Clinical Research Program Delivers New Results
2024-06-07 09:54 Erbe Elektromedizin inaugurates new competence center for medical instruments in Rangendingen, Germany, and expands its capacities for customers all over the world
2024-06-05 10:33 Bio-Sourcing and Afrigen Biologics partner on groundbreaking biomanufacturing platform to improve access to biotherapeutics in South Africa
2024-06-05 10:23 Philip Morris International Tops Forbes’ 2024 Net Zero Leaders List
2024-06-05 10:08 OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
2024-06-04 10:16 Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
2024-06-04 10:08 Merck’s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment
2024-06-04 10:03 Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM™ Wearable Continuous Vital Signs Monitors
2024-06-03 13:00 Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
2024-06-03 09:55 Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
2024-06-03 09:51 Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2024-05-31 16:31 Morinaga Milk’s New Research Breakthrough Backed the Superiority of its Human-Residential Bifidobacteria (HRB) Strains in Metabolizing Toxin Precursor in the Gut
2024-05-31 15:18 Quit Like Sweden Urges Progressive Tobacco Control to Save Millions of Lives on World No Tobacco Day

Business Wire Weibo

Press Releases

Latest Releases